Human-first drug discovery platform that maps population-scale human biology using groundbreaking biological and computational tools to replace animal testing.
Parallel Bio is building a population-scale atlas of human biology to enable human-first drug discovery. Their platform uses biological and computational tools combined with a growing biobank of patient samples to rapidly chart human disease biology, enabling drug target discovery, precision medicine, and foundation model development. By overcoming the 97% drug failure rate caused by reliance on animal models, Parallel Bio offers pharma partners a path from disease target to IND at a fraction of traditional time and cost. Parallel Bio is a product of Parallel Bio.